Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03766009 · ClinicalTrials.gov registry record · NA
Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making
A NA study of Breast Cancer Stage II and Breast Cancer Stage III, sponsored by Alliance for Clinical Trials in Oncology.
- Active
- Registry status
- NA
- Development phase
- 627
- Enrollment target
- 20
- Study locations
NCT03766009 is a NA study of Breast Cancer Stage II and Breast Cancer Stage III that is active but no longer recruiting, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 627 participants, above the 153-participant average among 22 other Breast Cancer Stage II trials with a reported enrollment target (310% higher). The trial reports 20 study locations across 3 states.
The verdict
NCT03766009, a NA study of Breast Cancer Stage II and Breast Cancer Stage III, is active but no longer recruiting, sponsored by Alliance for Clinical Trials in Oncology.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 627 participants
- Enrollment target
- 20
- Study locations
Study Summary
This trial studies how well a breast cancer surgery decision aid works in increasing patient engagement in decision making for patients with newly diagnosed stage 0-III breast cancer. The trial also examines barriers to patient engagement even with the use of a decision aid, and if barriers are more likely to be experienced by socioeconomically disadvantaged patients.
Conditions Studied
Interventions
- OTHER Usual Care
- OTHER Web-based decision aid
Study Locations (20)
Hawaii
- Hawaii Cancer Care Inc - Waterfront Plaza - Honolulu
- Island Urology - Honolulu
- Queen's Cancer Cenrer - POB I - Honolulu
- Queen's Medical Center - Honolulu
- Straub Clinic and Hospital - Honolulu
- University of Hawaii Cancer Center - Honolulu
- Hawaii Cancer Care Inc-Liliha - Honolulu
- Kuakini Medical Center - Honolulu
- Queen's Cancer Center - Kuakini - Honolulu
- The Cancer Center of Hawaii-Liliha - Honolulu
- Kapiolani Medical Center for Women and Children - Honolulu
- Wilcox Memorial Hospital and Kauai Medical Clinic - Lihue
California
- Epic Care-Dublin - Dublin
- Bay Area Breast Surgeons Inc - Emeryville
- Epic Care Partners in Cancer Care - Emeryville
- Contra Costa Regional Medical Center - Martinez
- Alta Bates Summit Medical Center - Summit Campus - Oakland
- Bay Area Tumor Institute - Oakland
- Epic Care Cyberknife Center - Walnut Creek
Georgia
- Augusta University Medical Center - Augusta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 627 participants |
| Start Date | 2019-06-05 |
| Est. Completion | 2026-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03766009
The ClinicalTrials.gov registry entry for NCT03766009 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 627 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 153-participant average among 22 other Breast Cancer Stage II trials with a reported enrollment target (310% higher). The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Breast Cancer Stage II appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT03766009 reports 20 study locations spanning 3 distinct geographic areas - top geographies include Hawaii, California, Georgia.
Frequently Asked Questions
What is clinical trial NCT03766009 about?
NCT03766009 is a clinical study titled "Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making". This trial studies how well a breast cancer surgery decision aid works in increasing patient engagement in decision making for patients with newly diagnosed stage 0-III breast cancer. The trial also examines barriers to patient engagement even with the use of a decision aid, and if barriers are more...
What is the current status of trial NCT03766009?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 627 participants. The study started on 2019-06-05. Estimated completion is 2026-12-15.
What conditions does trial NCT03766009 study?
This clinical trial studies the following conditions: Breast Cancer Stage II, Breast Cancer Stage III, Breast Cancer Stage I, Breast Cancer Stage 0.
What interventions are being tested in trial NCT03766009?
The interventions under investigation include: Usual Care (OTHER), Web-based decision aid (OTHER).
Who is sponsoring clinical trial NCT03766009?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03766009 being conducted?
This trial has 20 study locations across California, Georgia, Hawaii. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer Stage II
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial
RECRUITING · NA
-
Optimizing Surgical Decisions in Young Adults With Breast Cancer
RECRUITING · NA
-
Evaluation of Radiobiological Effects in Skin Toxicities for Breast Cancer Patients With Pencil Beam Scanning Proton Therapy
RECRUITING · NA
-
A Study of Language Interpretation Solutions for People With Breast Cancer
RECRUITING · NA
-
A Study of the TheraBionic P1 Device in Breast Cancer
RECRUITING · NA
-
Abbreviated MBCT for Depression in Older African American/Black Breast Cancer Survivors
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.